381 related articles for article (PubMed ID: 34968160)
41. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
42. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
[TBL] [Abstract][Full Text] [Related]
43. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
[TBL] [Abstract][Full Text] [Related]
44. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X; Kong C; Wu Y
Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
[TBL] [Abstract][Full Text] [Related]
45. miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.
Song L; Peng L; Hua S; Li X; Ma L; Jie J; Chen D; Wang Y; Li D
Biomed Res Int; 2018; 2018():5109497. PubMed ID: 29850528
[TBL] [Abstract][Full Text] [Related]
46. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
47. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
49. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
Zheng S; Wang C; Yan H; Du Y
Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
[TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
[TBL] [Abstract][Full Text] [Related]
51. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
Tan Z; Cao F; Jia B; Xia L
Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
[TBL] [Abstract][Full Text] [Related]
52. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
53. MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC.
Xie WB; Liang LH; Wu KG; Wang LX; He X; Song C; Wang YQ; Li YH
Cell Physiol Biochem; 2018; 46(2):654-663. PubMed ID: 29617683
[TBL] [Abstract][Full Text] [Related]
54. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
55. CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis.
Xu L; Long H; Zhou B; Jiang H; Cai M
Curr Eye Res; 2021 Nov; 46(11):1751-1761. PubMed ID: 33988065
[No Abstract] [Full Text] [Related]
56. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
Liao Y; Cao L; Wang F; Pang R
J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis.
Du R; Jiang F; Yin Y; Xu J; Li X; Hu L; Wang X
Int J Immunopathol Pharmacol; 2021; 35():2058738420966087. PubMed ID: 33583218
[TBL] [Abstract][Full Text] [Related]
58. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
59. Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.
Büttner R; Gosney JR; Skov BG; Adam J; Motoi N; Bloom KJ; Dietel M; Longshore JW; López-Ríos F; Penault-Llorca F; Viale G; Wotherspoon AC; Kerr KM; Tsao MS
J Clin Oncol; 2017 Dec; 35(34):3867-3876. PubMed ID: 29053400
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-4458 Regulates PD-L1 Expression to Enhance Anti-tumor Immunity in NSCLC via Targeting STAT3.
Liu W; Liu R; Yuan R; Wang X
Mol Biotechnol; 2021 Dec; 63(12):1268-1279. PubMed ID: 34386930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]